 | • レポートコード：D0GIR-06139 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：化学、材料 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、経口固形剤形（OSDF）および医薬品添加物の世界市場を広く調査・分析し、今後の市場展望をまとめております。経口固形剤形（OSDF）および医薬品添加物の種類別市場規模（グリセリン、プロピレングリコール、ソルビトール、マンニトール、その他）、用途別市場規模（工業用、非工業用）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：ABITEC Corporation、Cargill、BASF、AkzoNobel、J.M. Huber Corporation、Archer Daniels Midland (ADM)、Evonik、DowDuPont、Eastman Chemical Company ・地域別グローバル市場分析 2015年-2020年 ・経口固形剤形（OSDF）および医薬品添加物の北米市場（アメリカ、カナダ、メキシコ） ・経口固形剤形（OSDF）および医薬品添加物のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・経口固形剤形（OSDF）および医薬品添加物のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・経口固形剤形（OSDF）および医薬品添加物の南米市場（ブラジル、アルゼンチン） ・経口固形剤形（OSDF）および医薬品添加物の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：グリセリン、プロピレングリコール、ソルビトール、マンニトール、その他 ・用途別分析：工業用、非工業用 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Oral Solid Dosage Forms (OSDF) and Pharma Excipients market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Oral Solid Dosage Forms (OSDF) and Pharma Excipients market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Oral Solid Dosage Forms (OSDF) and Pharma Excipients market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Oral Solid Dosage Forms (OSDF) and Pharma Excipients market has been segmented into
Glycerin
Propylene Glycol
Sorbitol
Mannitol
Others
By Application, Oral Solid Dosage Forms (OSDF) and Pharma Excipients has been segmented into:
Industrial Application
Non-industrial Application
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Oral Solid Dosage Forms (OSDF) and Pharma Excipients market presented in the report. This section sheds light on the sales growth of different regional and country-level Oral Solid Dosage Forms (OSDF) and Pharma Excipients markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Oral Solid Dosage Forms (OSDF) and Pharma Excipients market.
The report offers in-depth assessment of the growth and other aspects of the Oral Solid Dosage Forms (OSDF) and Pharma Excipients market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share Analysis
Oral Solid Dosage Forms (OSDF) and Pharma Excipients competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Oral Solid Dosage Forms (OSDF) and Pharma Excipients sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Oral Solid Dosage Forms (OSDF) and Pharma Excipients sales, revenue and market share for each player covered in this report.
The major players covered in Oral Solid Dosage Forms (OSDF) and Pharma Excipients are:
ABITEC Corporation
Cargill
BASF
AkzoNobel
J.M. Huber Corporation
Archer Daniels Midland (ADM)
Evonik
DowDuPont
Eastman Chemical Company
Among other players domestic and global, Oral Solid Dosage Forms (OSDF) and Pharma Excipients market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Solid Dosage Forms (OSDF) and Pharma Excipients product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oral Solid Dosage Forms (OSDF) and Pharma Excipients, with price, sales, revenue and global market share of Oral Solid Dosage Forms (OSDF) and Pharma Excipients in 2018 and 2019.
Chapter 3, the Oral Solid Dosage Forms (OSDF) and Pharma Excipients competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Solid Dosage Forms (OSDF) and Pharma Excipients breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Oral Solid Dosage Forms (OSDF) and Pharma Excipients market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Oral Solid Dosage Forms (OSDF) and Pharma Excipients sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Glycerin
1.2.3 Propylene Glycol
1.2.4 Sorbitol
1.2.5 Mannitol
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Industrial Application
1.3.3 Non-industrial Application
1.4 Overview of Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market
1.4.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 ABITEC Corporation
2.1.1 ABITEC Corporation Details
2.1.2 ABITEC Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 ABITEC Corporation SWOT Analysis
2.1.4 ABITEC Corporation Product and Services
2.1.5 ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Cargill
2.2.1 Cargill Details
2.2.2 Cargill Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Cargill SWOT Analysis
2.2.4 Cargill Product and Services
2.2.5 Cargill Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 BASF
2.3.1 BASF Details
2.3.2 BASF Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 BASF SWOT Analysis
2.3.4 BASF Product and Services
2.3.5 BASF Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 AkzoNobel
2.4.1 AkzoNobel Details
2.4.2 AkzoNobel Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 AkzoNobel SWOT Analysis
2.4.4 AkzoNobel Product and Services
2.4.5 AkzoNobel Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 J.M. Huber Corporation
2.5.1 J.M. Huber Corporation Details
2.5.2 J.M. Huber Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 J.M. Huber Corporation SWOT Analysis
2.5.4 J.M. Huber Corporation Product and Services
2.5.5 J.M. Huber Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Archer Daniels Midland (ADM)
2.6.1 Archer Daniels Midland (ADM) Details
2.6.2 Archer Daniels Midland (ADM) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Archer Daniels Midland (ADM) SWOT Analysis
2.6.4 Archer Daniels Midland (ADM) Product and Services
2.6.5 Archer Daniels Midland (ADM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Evonik
2.7.1 Evonik Details
2.7.2 Evonik Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Evonik SWOT Analysis
2.7.4 Evonik Product and Services
2.7.5 Evonik Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 DowDuPont
2.8.1 DowDuPont Details
2.8.2 DowDuPont Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 DowDuPont SWOT Analysis
2.8.4 DowDuPont Product and Services
2.8.5 DowDuPont Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Eastman Chemical Company
2.9.1 Eastman Chemical Company Details
2.9.2 Eastman Chemical Company Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Eastman Chemical Company SWOT Analysis
2.9.4 Eastman Chemical Company Product and Services
2.9.5 Eastman Chemical Company Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturer Market Share in 2019
3.3.2 Top 6 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue and Market Share by Regions
4.1.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Market Share by Regions (2015-2020)
4.1.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Market Share by Regions (2015-2020)
4.2 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020)
4.3 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020)
4.5 South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue and Market Share by Country
5.1.1 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Market Share by Country (2015-2020)
5.1.2 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Market Share by Country (2015-2020)
5.2 United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020)
5.3 Canada Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020)
5.4 Mexico Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue and Market Share by Country
6.1.1 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Market Share by Country (2015-2020)
6.1.2 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Market Share by Country (2015-2020)
6.2 Germany Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020)
6.3 UK Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020)
6.4 France Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020)
6.5 Russia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020)
6.6 Italy Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Market Share by Regions (2015-2020)
7.2 China Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020)
7.3 Japan Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020)
7.4 Korea Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020)
7.5 India Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020)
7.7 Australia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue and Market Share by Country
8.1.1 South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Market Share by Country (2015-2020)
8.1.2 South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Market Share by Country (2015-2020)
8.2 Brazil Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020)
8.3 Argentina Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020)
9.3 Turkey Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020)
9.4 Egypt Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020)
9.5 South Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Market Share by Type (2015-2020)
10.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Market Share by Type (2015-2020)
10.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Type (2015-2020)
11 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Segment by Application
11.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Application (2015-2020)
11.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Application (2015-2020)
11.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Application (2015-2020)
12 Market Forecast
12.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue and Growth Rate (2021-2025)
12.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Forecast by Regions (2021-2025)
12.2.1 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Forecast (2021-2025)
12.2.2 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Forecast (2021-2025)
12.2.3 Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Forecast (2021-2025)
12.2.4 South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Forecast (2021-2025)
12.2.5 Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Forecast (2021-2025)
12.3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Forecast by Type (2021-2025)
12.3.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast by Type (2021-2025)
12.3.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share Forecast by Type (2021-2025)
12.4 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Forecast by Application (2021-2025)
12.4.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast by Application (2021-2025)
12.4.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. ABITEC Corporation Basic Information, Manufacturing Base and Competitors
Table 8. ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Major Business
Table 9. ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Total Revenue (USD Million) (2018-2019)
Table 10. ABITEC Corporation SWOT Analysis
Table 11. ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product and Services
Table 12. ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Cargill Basic Information, Manufacturing Base and Competitors
Table 14. Cargill Oral Solid Dosage Forms (OSDF) and Pharma Excipients Major Business
Table 15. Cargill Oral Solid Dosage Forms (OSDF) and Pharma Excipients Total Revenue (USD Million) (2018-2019)
Table 16. Cargill SWOT Analysis
Table 17. Cargill Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product and Services
Table 18. Cargill Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. BASF Basic Information, Manufacturing Base and Competitors
Table 20. BASF Oral Solid Dosage Forms (OSDF) and Pharma Excipients Major Business
Table 21. BASF Oral Solid Dosage Forms (OSDF) and Pharma Excipients Total Revenue (USD Million) (2018-2019)
Table 22. BASF SWOT Analysis
Table 23. BASF Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product and Services
Table 24. BASF Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. AkzoNobel Basic Information, Manufacturing Base and Competitors
Table 26. AkzoNobel Oral Solid Dosage Forms (OSDF) and Pharma Excipients Major Business
Table 27. AkzoNobel Oral Solid Dosage Forms (OSDF) and Pharma Excipients Total Revenue (USD Million) (2018-2019)
Table 28. AkzoNobel SWOT Analysis
Table 29. AkzoNobel Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product and Services
Table 30. AkzoNobel Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. J.M. Huber Corporation Basic Information, Manufacturing Base and Competitors
Table 32. J.M. Huber Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Major Business
Table 33. J.M. Huber Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Total Revenue (USD Million) (2018-2019)
Table 34. J.M. Huber Corporation SWOT Analysis
Table 35. J.M. Huber Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product and Services
Table 36. J.M. Huber Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Archer Daniels Midland (ADM) Basic Information, Manufacturing Base and Competitors
Table 38. Archer Daniels Midland (ADM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Major Business
Table 39. Archer Daniels Midland (ADM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Total Revenue (USD Million) (2018-2019)
Table 40. Archer Daniels Midland (ADM) SWOT Analysis
Table 41. Archer Daniels Midland (ADM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product and Services
Table 42. Archer Daniels Midland (ADM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Evonik Basic Information, Manufacturing Base and Competitors
Table 44. Evonik Oral Solid Dosage Forms (OSDF) and Pharma Excipients Major Business
Table 45. Evonik Oral Solid Dosage Forms (OSDF) and Pharma Excipients Total Revenue (USD Million) (2018-2019)
Table 46. Evonik SWOT Analysis
Table 47. Evonik Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product and Services
Table 48. Evonik Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. DowDuPont Basic Information, Manufacturing Base and Competitors
Table 50. DowDuPont Oral Solid Dosage Forms (OSDF) and Pharma Excipients Major Business
Table 51. DowDuPont Oral Solid Dosage Forms (OSDF) and Pharma Excipients Total Revenue (USD Million) (2018-2019)
Table 52. DowDuPont SWOT Analysis
Table 53. DowDuPont Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product and Services
Table 54. DowDuPont Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Eastman Chemical Company Basic Information, Manufacturing Base and Competitors
Table 56. Eastman Chemical Company Oral Solid Dosage Forms (OSDF) and Pharma Excipients Major Business
Table 57. Eastman Chemical Company Oral Solid Dosage Forms (OSDF) and Pharma Excipients Total Revenue (USD Million) (2018-2019)
Table 58. Eastman Chemical Company SWOT Analysis
Table 59. Eastman Chemical Company Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product and Services
Table 60. Eastman Chemical Company Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Manufacturer (2018-2019) (K Units)
Table 62. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Manufacturer (2018-2019) (USD Million)
Table 63. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Regions (2015-2020) (K Units)
Table 64. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Regions (2015-2020)
Table 65. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Regions (2015-2020) (USD Million)
Table 66. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Countries (2015-2020) (K Units)
Table 67. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Countries (2015-2020)
Table 68. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Countries (2015-2020) (USD Million)
Table 69. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Countries (2015-2020)
Table 70. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Countries (2015-2020) (K Units)
Table 71. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Countries (2015-2020)
Table 72. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Countries (2015-2020) (USD Million)
Table 73. Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Regions (2015-2020) (K Units)
Table 74. Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Regions (2015-2020)
Table 75. Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Regions (2015-2020) (USD Million)
Table 76. South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Countries (2015-2020) (K Units)
Table 77. South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Countries (2015-2020)
Table 78. South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Countries (2015-2020) (USD Million)
Table 79. South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Countries (2015-2020)
Table 80. Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Countries (2015-2020) (K Units)
Table 81. Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Countries (2015-2020)
Table 82. Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Countries (2015-2020) (USD Million)
Table 83. Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Countries (2015-2020)
Table 84. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2015-2020) (K Units)
Table 85. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Share by Type (2015-2020)
Table 86. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2015-2020) (USD Million)
Table 87. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Share by Type (2015-2020)
Table 88. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2015-2020) (K Units)
Table 89. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Share by Application (2015-2020)
Table 90. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast by Regions (2021-2025) (K Units)
Table 91. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share Forecast by Regions (2021-2025)
Table 92. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast by Type (2021-2025) (K Units)
Table 93. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share Forecast by Type (2021-2025)
Table 94. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast by Application (2021-2025)
Table 95. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share Forecast by Application (2021-2025)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Picture
Figure 2. Global Sales Market Share of Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Type in 2019
Figure 3. Glycerin Picture
Figure 4. Propylene Glycol Picture
Figure 5. Sorbitol Picture
Figure 6. Mannitol Picture
Figure 7. Others Picture
Figure 8. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Application in 2018
Figure 9. Industrial Application Picture
Figure 10. Non-industrial Application Picture
Figure 11. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Manufacturer in 2019
Figure 32. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Regions (2015-2020)
Figure 39. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Regions in 2018
Figure 40. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020)
Figure 41. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020)
Figure 43. South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020)
Figure 45. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Countries (2015-2020)
Figure 47. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Countries in 2018
Figure 48. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Countries in 2018
Figure 50. United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Countries in 2019
Figure 56. Germany Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Regions 2019
Figure 64. China Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Countries in 2019
Figure 71. South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Countries in 2019
Figure 72. Brazil Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
OSDF溶解度向上賦形剤の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Solubility Enhancement Excipients for OSDF market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The So…- 医薬品及び賦形剤の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Pharmaceuticals and Excipients market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…
- バイオ医薬品添加剤の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Biopharmaceuticals Excipients market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 包装・ラベリング（ヘルスケア）サービスの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Packaging and Labeling (Healthcare) Services market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.1% in the forecast period of 2020 to 2025 and will expected to reach USD 101590 million by 2025, from USD 86640 million in 20…
- OTC外用薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global OTC Topical Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The OTC Topical Drugs market re…